Blog | Veristat Insightful Perspectives

Contact Veristat Now


Request A Proposal

Contact Us

Evolving Risk-Based Monitoring to Improve Clinical Studies

October 11, 2019

An Interview with Dunya Botetzayas, RN, Senior Director of Clinical Monitoring at Veristat

Read More

Regulatory Guidance Monthly Review - September 2019

October 2, 2019

September 2019 Updates from FDA 


Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA)  that are pertinent to the governance of clinical trials and drug, biologic, or medical device development and approval.   Below are the relevant links to updates provided in September 2019.

 

Read More